Mon 5/25/2020 17:38 ET
DJIA24465.169.790.04%TELCO163.610.670.41%GOLD1727.408.120.47%Shanghai2817.974.230.15%
S&P 5002955.457.090.24%BANKS310.942.710.87%OIL33.700.451.34%BITCOIN8916.58156.931.76%
NASDAQ9324.590.000.00%PHARM600.103.600.60%US/EU1.090.000.00%Futures2989.2536.171.21%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Keryx Biopharmaceuticals - KERX   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add KERX
  
From: SpecGuru (Rep: 63) reply to SpecGuruDate: 09/13/2016 15:27
Forum: Keryx Biopharmaceuticals - Msg #2600Thread #673868708 (Rec: 0)
Strong in this bloody market. Production resuming, sNDA, IDA filing, Bought-out, etc. coming in the next few months touching $5 Billion market. Expecting double digit market cap.
"...Keryx (NASDAQ:KERX) reported top-line results from its pivotal Phase 3 study that was intended to provide the basis for a label expansion of Auryxia. With these positive results, the company now intends to file a supplemental new drug application in the third quarter of 2016 seeking to expand Auryxia's indication to iron deficiency anemia.
IDA is a common complication of chronic kidney disease. Approximately, 1.6 million people living in the U.S. with stage 3-5 non-dialysis dependent chronic kidney disease (NDD-CKD) suffer from IDA. If Auryxia will be approved for the treatment of IDA in these patients, it would be the only FDA-approved iron treatment in a tablet form available to these patients...."
Re: I should say it has all short term, intermediate term and long term catalysts...



*****I am writing drunk*****



Reply to SpecGuru - Msg #2599 - 09/12/2016 15:11

I should say it has all short term, intermediate term and long term catalysts. Re: Flirting $7.00.
What would you like to do? Message: Endorse | Bookmark | Report AbuseUser SpecGuru: Reward | Watch | IgnoreKERX: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add KERX
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.